Top Stories

Uber has an application pending with the U.S. Patent and Trademark Office for using technology that would help the ride-hailing giant to detect drunk passengers. The patent application was initially filed by Uber in December 2016 and relates to predicting...

Japan had a merchandise trade deficit of 578.321 billion yen in May, the Ministry of Finance said on Monday. That missed expectations for a shortfall of 205.2 billion yen following the downwardly revised 624.6 billion yen surplus in April (originally...


President Donald Trump's former campaign chairman Paul Manafort is headed to jail after his bail was revoked by a District Court Judge on Friday. Manafort will remain in jail as he awaits trial on criminal charges related to his lobbying work for a...

Ahead of Friday's holiday for Eid-ul-Fitr, the Singapore stock market had moved lower in three straight sessions, surrendering almost 85 points or 2.6 percent along the way. The Straits Times Index now rests just above the 3,355-point plateau and it may...


President Donald Trump has lashed out at his known critic and Hollywood actor Robert De Niro over the remarks he made during Tony Awards ceremony at the weekend. Calling Robert De Niro "a very Low IQ individual," Trump said the Oscar winner has received...

asian-markets2_10jun18.jpg Asian stock markets are mixed on Monday with investors treading cautiously as trade-related tensions remained in focus after U.S. President Donald Trump abruptly withdrew his support for a joint communique at the conclusion of the weekend G-7 summit. Investors are also looking ahead to Trump's historic summit with North Korean leader Kim Jong Un set to take place in Singapore on Tuesday.
pharma-daily-060618.jpg Clinical trial data is an important catalyst, and trial results or any update on the clinical studies can send the biotech stocks soaring or stumbling depending upon the news. Listed below are some of the biotech/pharma stocks awaiting clinical trial catalysts this month.
Asian markets ended mostly higher on Monday, with investors shrugging off concerns about trade war and looking ahead to the outcome of a historic meeting between the U.S. President Donald Trump and the North Korean leader Kim Jong Un.
bitcoin-exchanges-061118.jpg Investigators from the US government, who are probing allegations of manipulation in Bitcoin market pricing, have sought comprehensive trading data from Bitcoin exchanges, the Wall Street Journal reported, citing people familiar with the matter.
Read More
trump3-061518.jpg Dealing a major blow to House Republican leaders that spent weeks crafting compromise immigration legislation, President Donald Trump declared Friday that he will not sign the bill. The comments from Trump come after House Speaker Paul Ryan, R-Wis.,...
Read More
paulryan-061318.jpg Apparently staving off a revolt by some moderate Republicans, House Speaker Paul Ryan, R-Wis., has said the House will consider two separate bills next week to address the young illegal immigrants known as DREAMers. The announcement by Ryan's office...
Read More
sec-june15.jpgCryptocurrencies strongly gained Thursday after a top SEC official said Bitcoin and Ether, the two leading cryptocurrencies in that order, cannot be treated as securities, but some initial coin offerings could be. When an asset is offered and sold in a way that causes investors to have a reasonable expectation of profits based on the efforts of others, it can be a security, William Hinman said.
Read More
One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More
Ahead of Friday's holiday for Eid-ul-Fitr, the Singapore stock market had moved lower in three straight sessions, surrendering almost 85 points or 2.6 percent along the way. The Straits Times Index now rests just above the 3,355-point plateau and it may take further damage again on Monday. The global...
Reigniting concerns about a global trade war, President Donald Trump announced plans to impose new tariffs on billions of dollars worth of Chinese imports on Friday. Trump said in a statement the U.S. will implement a 25 percent tariff on $50 billion of goods from China that contain "industrially significant technologies."
Read More
Swarm, blockchain for private equity, announced the launch of new tokens that represent equity in technology companies, starting with Coinbase, Robinhood and Ripple. This helps Swarm investors acquire security tokens representing fractional share in private companies. Swarm said each individual equity offering will have its own unique security token created using the SRC20 security token protocol. Read More
Shares of commercial-stage biotechnology and regenerative biomaterials company PolarityTE Inc (COOL) touched a new 52-week high of $33.22 on Friday. We had alerted our premium subscribers to this stock on April 30, 2018 (Report titled "Cool & Hot") when it was trading around $17.60. Read More
Bristol-Myers Squibb Company (BMY) announced that the China National Drug Administration has approved Opdivo or nivolumab injection for the treatment of locally advanced or metastatic non-small cell lung cancer or NSCLC after prior platinum-based chemotherapy... Read More
ripple-june15.jpg The University of Texas at Austin has announced research on blockchain technology, sponsored by Ripple. The San Francisco-based distributed ledger technology startup has pledged $2 million to fund the research by McCombs School of Business's Blockchain Initiative over the next five years. The University of Texas is one of 17 academic institutions around the world to receive funding from Ripple i
Read More
Follow RTT
Economic Calendar
06/17/18 19:50ExportsMAY Japan
06/17/18 19:50ImportsMAY Japan
06/17/18 19:50Trade BalanceMAY Japan
06/17/18 19:1Rightmove House Prices (M-o-M)JUN UK
06/17/18 19:1Rightmove House Prices (Y-o-Y)JUN UK
06/15/18 16:0Net Long-term TIC FlowsAPR United States
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
09/05/18RHHBYTECENTRIQ (sBLA)FDA decision on TECENTRIQ in combination with Avastin or bevacizumab, paclitaxel and carboplatin or chemotherapy for initial treatment of people with metastatic NSCLC
09/03/18ADMPSymjepi (sNDA)FDA decision on low dose Symjepi (0.15mg) for the emergency treatment of anaphylaxis
08/30/18AKCAVolanesorsen (NDA)FDA decision on Volanesorsen for the treatment of familial chylomicronemia syndrome (FCS).
08/28/18TTPHEravacycline (NDA) FDA decision on Eravacycline for the treatment of complicated intra-abdominal infections
08/24/18KALAInveltys (NDA)FDA decision on Inveltys for post surgical pain and inflammation
View All